23,000 people follow me on LinkedIn. They are patients, caregivers, and clinicians dealing with insurance denials, medical debt, and delays in care. Here is what they are seeing every day and why it reflects a much larger problem across US healthcare.

Dr. Hesham Hassaballa is board certified four times over with 20 years in the ICU. When his daughter was getting chemo, he checked his insurance portal daily, terrified they would drop her. A physician. In the system. Earning a good living. Still terrified of financial ruin because his child got sick.

Prior authorization persists because it works for the system that created it. This essay explains how cost control, risk management, and delay shape patient outcomes, why reform keeps falling short, and what must change to align financial incentives with timely care.

Only 0.2% of patients appeal insurance denials, yet 80% succeed. This article examines how even small increases in appeals could shift insurer behavior, raise costs, influence Wall Street expectations, and reshape the economics of American healthcare.

American healthcare delays care and denies treatment by design. Insurance rules, prior authorization, and administrative barriers control access to care, often slowing or blocking what doctors recommend and patients need.

A 30 year brain cancer survivor breaks down how insurance delays, denials, and red tape harm patients by design. This is not dysfunction. This is the business model.

Mark Cuban is stepping in where insurers fail, funding care and challenging the system. But real change will not come from policy alone. A unified patient voting bloc could reshape healthcare power in America.

Matthew Zachary joins Humanity Rx to break down how modern cancer care improves survival while leaving patients exposed to medical debt, prior authorization delays, and financial risk, and why policy change depends on organized patient power.

When an insurer labels trigeminal nerve blocks investigational, patients may face brain surgery instead. This essay examines how coverage policy, coding decisions, and actuarial incentives shape care for trigeminal neuralgia and what must change to align patient protection with economic logic.

Gallup reports 82 million Americans cut back on daily life to afford healthcare. Coverage shifts financial risk to families through deductibles and prior authorization. Diagnosis now operates like a private tax on survival and forces tradeoffs across work, housing, and retirement.

I do not have insider sources. I have Google Alerts. Set up 19 targeted alerts and watch insurance denials, cancer treatment delays, lawsuits, and settlements roll in daily. The stories are public. The patterns are obvious. Here is how to see what I see.

Sally Neely Nix manages chronic pain with nerve block injections. No opioids. Her insurer calls them experimental. So she built a policy brief and sent it to the CEO. While in extreme pain. Patients shouldn't have to become researchers to access care that works.

Health systems consolidate. Insurers post record profits. Employers spend $20,000 per employee on coverage while workers fight denials alone at 11 pm. Insurance middlemen now cost more than the drugs. The system rewards delay and calls it complexity. Families call it Tuesday.

Mount Sinai and Anthem fight over 450 million dollars while 200000 patients scramble to keep their doctors and cancer treatment. Corporate contract disputes now function as leverage tactics, turning patients into bargaining chips in rate negotiations.

Blue Cross Blue Shield says insurers protect patients from high drug prices. The real world shows delays, denials, and blame shifting while patients wait, appeal, and deteriorate. A closer look at how insurers deflect responsibility in the drug pricing debate.

A new KFF poll shows prior authorization now ranks as the biggest burden in American healthcare. Delays and denials affect nearly half of insured adults, with severe mental, financial, and physical consequences. Patients across every plan agree.

We The Patients LIVE Raleigh brought patients clinicians policymakers and journalists into the same room to confront how healthcare harm actually forms. What emerged was clarity accountability and the beginning of a different kind of conversation about power trust and consequence.

Health insurers turned “medically necessary” into a denial weapon. This article breaks down how coverage policies, anonymous medical directors, and financial incentives allow insurers to override doctors and block cancer care, then outlines concrete fixes that could shut the system down.

Insurance companies promise reform while patients absorb delay and denial. From IVIG rejections to cancer imaging hold ups, this essay documents how prior authorization functions in real life and why patients now recognize the pattern.

An open letter to Mark Cuban on why the Great Healthcare Plan fails patients. It leaves PBM power intact, ignores pricing abuse, and turns transparency into theater. Patients already know how often claims get denied. We live it every day.